October 19, 2017 6:42 PM ET

Biotechnology

Company Overview of Labrys Biologics, Inc.

Key Executives for Labrys Biologics, Inc.

NameBoard RelationshipsTitleAge
Corey S. Goodman Ph.D.96 RelationshipsFounder and Chairman60
Marcelo Bigal M.D., Ph.D.No RelationshipsChief Medical Officer--
Michael Chang Ph.D.No RelationshipsVice President of Project Management--
Rafael Escandón Ph.D., MPHNo RelationshipsVice President of Clinical Operations--
Henry Stern No RelationshipsExecutive Director of CMC--

Labrys Biologics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Corey S. Goodman Ph.D. 96 RelationshipsSecond Genome, Inc.60
Wende S. Hutton MBA 66 RelationshipsCanaan Partners57
Nina S. Kjellson 72 RelationshipsCanaan Partners42
Michael F. Powell Ph.D. 77 RelationshipsSofinnova Ventures, Inc.62
Steven P. James 27 RelationshipsAntiva Biosciences, Inc.59
View All Board Members

Labrys Biologics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.5K
Bonus
244.7K
Total Short Term Compensation
487.0K
Total Value of Options
17.9M
Compensation as of Fiscal Year
Labrys Biologics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

PolyNovo Announces Change of Company Secretary
October 19, 2017 4:31 AM ET
Marina Biotech, Inc. Appoints Peter D. Weinstein as Chief Legal Officer, Effective October 12, 2017
October 18, 2017 9:01 PM ET
Spectral Medical Inc Announces Retirement of Tony Businskas as Executive Vice President and CFO
October 18, 2017 12:00 PM ET
Tissue Regenix Group plc Announces Executive Changes
October 18, 2017 6:00 AM ET
Monash IVF Group Ltd. Announces the Appointment of David Morris as Chief Executive Officer and Managing Director, Effective 13 November 2017
October 17, 2017 10:12 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Labrys Biologics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.